Literatuurreferenties
1. IB-tekst strontiumranelaat (Prostelos®) via: www.cbg-meb.nl, Geneesmiddeleninformatiebank.
2. Meunier PJ, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004; 350: 459-468.
3. Reginster JY, et al. Strontium ranelate reduces the risk of nonvertebral fractures in post-menopausal women with osteoporosis. J Clin Endocrinol Metab 2005; 90: 2816-2822.
4. CFH-rapport strontiumranelaat (Protelos®) via: www.cvz.nl, CFH-rapporten.
